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Dear Editor, 
The article by Ramkumar and Basti[1]
 
describes the acute onset of a bilateral cataract related to the onset 
of diabetes, and the eventual reversal of the lens opacities after accomplishing a fall in blood glucose 
levels with insulin therapy. Reports of this ocular manifestation of diabetes, also called “acute sugar 
cataract”, are scarce[2]. 
The development of a reversible lens opacification in human diabetics is associated with changes in 
the lens hydration producing oedema, vacuole formation, and increased membrane permeability[3]. In 
addition, other mechanisms, such as oxidative stress, are involved. 
As described by the authors[1], the typical morphology of these cataracts is a subcapsular opacity. 
This peculiar appearance resembling a rosette is due to the fact that the cortical sutures of the lens act as a 
backbone and, thus, opacities radiate from a central subcapsular plaque towards the periphery. 
Conversely, the resolution of the opacification follows a centripetal direction due to the repair or 
formation of new lens fibres by the equatorial epithelial cells[4]. 
The patient may complain of blurred vision as a consequence of oedema producing a disruption of the 
orderly arranged lens fibres and altering their transparency, and also because of transient changes in the 
lens refractive index[3]. In most of the cases, the symptoms are reversed once glucose levels are under 
control. However, if hyperglycaemia persists, alterations in cell membrane may produce electrolyte and 
biochemical changes that cause cell death and irreversible cataracts.  
Different experimental studies help to explain the pathogenesis of the cataracts in these cases[5]. 
Under normal conditions, the main source of energy of the human lens is glucose, which is metabolised 
through the glycolytic pathway. When blood glucose levels are high in diabetic patients, the lens is 
exposed to a hyperosmotic aqueous humour and a progressive increase of its glucose concentration is 
produced. This fact causes a saturation of the glycolytic pathway and the activation of the sorbitol 
pathway, with an increase in aldose reductase activity. Glucose is then converted to sorbitol and fructose, 
and a depletion of nicotinamide adenine dinucleotide phosphate ensues. 
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The accumulation of these substances within the lens fibres creates an osmotic hydration of the tissue, 
with a gradual swelling of the lens. When normal levels of glycaemia are restored, an excess of sorbitol 
persists in the lens, as it diffuses more slowly than glucose. Because of that sustained lens osmolality, 
water is still drawn into the lens, increasing the swelling. Jacob and Duncan[6] called this phenomenon 
“double osmotic shock”, and this fact explains why refractive changes may persist some weeks after the 
restoration of glucose levels. 
In summary, the case reported emphasises that in patients developing an acute cataract, a systemic 
evaluation should be done to rule out diabetes mellitus or other metabolic disorders. In addition, because 
of the potential reversibility of this type of cataract, in most instances surgical procedures will be 
unnecessary. 
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